Lonza | LONN - Interest Expense On Debt



Lonza reported CHF70M in Interest Expense on Debt for its fiscal semester ending in December of 2024.


Interest Expense On Debt Change Date
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 49M 1000K Mar/2025
AstraZeneca 303M 126M Jun/2025
BASF EUR 222M 4M Jun/2025
Bayer 495M 89M Jun/2025
Beiersdorf EUR 7.5M 4.5M Jun/2025
Covestro EUR 39M 6M Sep/2024
Demant 435M 27M Jun/2025
Fresenius 86M 30M Jun/2025
Fresenius Medical Care EUR 96.58M 15.58M Jun/2025
Geberit 7.9M 300K Mar/2025
Genmab DKK 9M 4M Jun/2025
Givaudan CHF 28M 28M Jun/2024
GlaxoSmithKline 184M 22M Jun/2025
GN Store Nord 297M 69M Jun/2025
Hikma Pharmaceutical 22M 9M Jun/2024
Merck 79M 1000K Jun/2025
Novartis USD 289M 19M Jun/2025
Philips 80M 24M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025
Sika AG CHF 47.4M 500K Jun/2024
Smith & Nephew 69M 1000K Jun/2025
Solvay EUR 25M 0 Jun/2025
UCB 108M 16M Dec/2024